8-KLeadership Changes

INTUITIVE SURGICAL INC 8-K Report, Executive Changes (Jul 30, 2014)

Filed July 30, 2014For Securities:ISRG

Summary

Intuitive Surgical, Inc. (ISRG) filed an 8-K report on July 29, 2014, detailing changes in executive compensation and an officer appointment. The Compensation Committee and Board of Directors approved adjustments to the annual base salaries for key executives, including the CEO, Gary Guthart, effective August 1, 2014. These adjustments reflect an increase in base compensation across the named executive officers, with the CEO's new base salary set at $625,000. Furthermore, the report announces the appointment of David Rosa as Executive Vice President and Chief Scientific Officer, effective immediately. In conjunction with his promotion, Mr. Rosa was granted stock options and restricted stock units (RSUs) under the company's incentive award plan. The vesting schedules for these equity awards are detailed, aligning executive incentives with long-term company performance and employee retention.

Key Highlights

  • 1Base salary adjustments approved for key executives, including CEO Gary Guthart, effective August 1, 2014.
  • 2CEO Gary Guthart's annual base salary increased by $65,000 to a new total of $625,000.
  • 3Other named executive officers also received base salary increases, with new salaries ranging from $310,000 to $425,000.
  • 4David Rosa appointed as Executive Vice President and Chief Scientific Officer, effective immediately.
  • 5David Rosa granted 4,500 stock options and 1,500 RSUs upon his promotion.
  • 6Stock options for David Rosa vest over a period starting six months after the grant date, with a monthly vesting schedule thereafter.
  • 7RSUs granted to David Rosa vest in quarterly increments over a four-year period.

Frequently Asked Questions

The filing indicates that the Compensation Committee of the Board of Directors recommended and the Board approved these base salary adjustments. While the exact reasons are not explicitly stated beyond 'adjustments,' such actions are typically taken to ensure competitive compensation, recognize performance, and retain key talent within the company.

David Rosa's promotion to Executive Vice President and Chief Scientific Officer signifies a recognition of his contributions and expanded responsibilities. The grant of stock options and RSUs serves as an incentive, aligning his financial interests with the long-term success and stock performance of Intuitive Surgical. The vesting schedules are designed to encourage continued service with the company.

David Rosa's stock options vest starting with 1/8th of the total shares at the end of six months, followed by monthly vesting of 1/48th of the total thereafter, provided he remains employed. His RSUs vest in one-quarter increments annually over a four-year period, also contingent on continued service.

The adjusted base salaries are effective August 1, 2014. David Rosa's promotion was effective immediately upon appointment on July 24, 2014, and his equity awards have a grant date of August 7, 2014.